179 related articles for article (PubMed ID: 38115107)
1. Preclinical assessment of an anti-HTLV-1 heterologous DNA/MVA vaccine protocol expressing a multiepitope HBZ protein.
Daian E Silva DSO; Cox LJ; Rocha AS; Lopes-Ribeiro Á; Souza JPC; Franco GM; Prado JLC; Pereira-Santos TA; Martins ML; Coelho-Dos-Reis JGA; Gomes-de-Pinho TM; Da Fonseca FG; Barbosa-Stancioli EF
Virol J; 2023 Dec; 20(1):304. PubMed ID: 38115107
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor.
Sugata K; Yasunaga J; Mitobe Y; Miura M; Miyazato P; Kohara M; Matsuoka M
Blood; 2015 Aug; 126(9):1095-105. PubMed ID: 26063164
[TBL] [Abstract][Full Text] [Related]
3. In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome.
Hilburn S; Rowan A; Demontis MA; MacNamara A; Asquith B; Bangham CR; Taylor GP
J Infect Dis; 2011 Feb; 203(4):529-36. PubMed ID: 21208912
[TBL] [Abstract][Full Text] [Related]
4. HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression.
Yamamoto-Taguchi N; Satou Y; Miyazato P; Ohshima K; Nakagawa M; Katagiri K; Kinashi T; Matsuoka M
PLoS Pathog; 2013 Sep; 9(9):e1003630. PubMed ID: 24068936
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocyte lysis of HTLV-1 infected cells is limited by weak HBZ protein expression, but non-specifically enhanced on induction of Tax expression.
Rowan AG; Suemori K; Fujiwara H; Yasukawa M; Tanaka Y; Taylor GP; Bangham CR
Retrovirology; 2014 Dec; 11():116. PubMed ID: 25499803
[TBL] [Abstract][Full Text] [Related]
6. Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals.
Enose-Akahata Y; Abrams A; Massoud R; Bialuk I; Johnson KR; Green PL; Maloney EM; Jacobson S
Retrovirology; 2013 Feb; 10():19. PubMed ID: 23405908
[TBL] [Abstract][Full Text] [Related]
7. The Human T-Cell Leukemia Virus Type 1 Basic Leucine Zipper Factor Attenuates Repair of Double-Stranded DNA Breaks via Nonhomologous End Joining.
Rushing AW; Hoang K; Polakowski N; Lemasson I
J Virol; 2018 Aug; 92(15):. PubMed ID: 29769340
[TBL] [Abstract][Full Text] [Related]
8. HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT).
Yasuma K; Yasunaga J; Takemoto K; Sugata K; Mitobe Y; Takenouchi N; Nakagawa M; Suzuki Y; Matsuoka M
PLoS Pathog; 2016 Jan; 12(1):e1005372. PubMed ID: 26735971
[TBL] [Abstract][Full Text] [Related]
9. Expression of a protein involved in bone resorption, Dkk1, is activated by HTLV-1 bZIP factor through its activation domain.
Polakowski N; Gregory H; Mesnard JM; Lemasson I
Retrovirology; 2010 Jul; 7():61. PubMed ID: 20653953
[TBL] [Abstract][Full Text] [Related]
10. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
Marín MQ; Pérez P; Ljungberg K; Sorzano CÓS; Gómez CE; Liljeström P; Esteban M; García-Arriaza J
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674625
[TBL] [Abstract][Full Text] [Related]
11. A multigene HIV type 1 subtype C modified vaccinia Ankara (MVA) vaccine efficiently boosts immune responses to a DNA vaccine in mice.
Shephard E; Burgers WA; Van Harmelen JH; Monroe JE; Greenhalgh T; Williamson C; Williamson AL
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):207-17. PubMed ID: 18240963
[TBL] [Abstract][Full Text] [Related]
12. HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation.
Narita T; Ishida T; Masaki A; Suzuki S; Ito A; Mori F; Yamada T; Ri M; Kusumoto S; Komatsu H; Miyazaki Y; Takatsuka Y; Utsunomiya A; Niimi A; Iida S; Ueda R
J Immunol; 2014 Feb; 192(3):940-7. PubMed ID: 24363428
[TBL] [Abstract][Full Text] [Related]
13. HTLV-1 Hbz protein, but not hbz mRNA secondary structure, is critical for viral persistence and disease development.
Maksimova V; Wilkie T; Smith S; Phelps C; Melvin C; Yu L; Niewiesk S; Green PL; Panfil AR
PLoS Pathog; 2023 Jun; 19(6):e1011459. PubMed ID: 37327244
[TBL] [Abstract][Full Text] [Related]
14. Human T-Cell Leukemia Virus Type 1 (HTLV-1) bZIP Factor Upregulates the Expression of ICAM-1 To Facilitate HTLV-1 Infection.
Fazio AL; Kendle W; Hoang K; Korleski E; Lemasson I; Polakowski N
J Virol; 2019 Oct; 93(19):. PubMed ID: 31315993
[TBL] [Abstract][Full Text] [Related]
15. HLA class I binding of HBZ determines outcome in HTLV-1 infection.
Macnamara A; Rowan A; Hilburn S; Kadolsky U; Fujiwara H; Suemori K; Yasukawa M; Taylor G; Bangham CR; Asquith B
PLoS Pathog; 2010 Sep; 6(9):e1001117. PubMed ID: 20886101
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP.
Mozhgani SH; Jaberi N; Rezaee SA; Bustani R; Jazayeri SM; Akbarin MM; Milani S; Tarokhian H; Norouzi M
J Med Virol; 2017 Jun; 89(6):1102-1107. PubMed ID: 27787900
[TBL] [Abstract][Full Text] [Related]
17. Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.
Kolibab K; Yang A; Derrick SC; Waldmann TA; Perera LP; Morris SL
Clin Vaccine Immunol; 2010 May; 17(5):793-801. PubMed ID: 20357059
[TBL] [Abstract][Full Text] [Related]
18. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells.
Satou Y; Yasunaga J; Yoshida M; Matsuoka M
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):720-5. PubMed ID: 16407133
[TBL] [Abstract][Full Text] [Related]
19. HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP.
Niederer HA; Laydon DJ; Melamed A; Elemans M; Asquith B; Matsuoka M; Bangham CR
Virol J; 2014 Sep; 11():172. PubMed ID: 25270762
[TBL] [Abstract][Full Text] [Related]
20. HTLV-1 bZIP Factor RNA and Protein Impart Distinct Functions on T-cell Proliferation and Survival.
Mitobe Y; Yasunaga J; Furuta R; Matsuoka M
Cancer Res; 2015 Oct; 75(19):4143-52. PubMed ID: 26383166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
